Application of a microsomal drug activation system in a human tumor cloning assay
- PMID: 6678855
- DOI: 10.1007/BF00180189
Application of a microsomal drug activation system in a human tumor cloning assay
Abstract
A commercially available preparation of livers from rats can be used to activate cyclophosphamide and DTIC in vitro. This activation can be done in such a way as to have utility in a soft agar cloning assay. The commercial S-9 fraction contains one or more factors which exert a direct inhibitory effect on the ability of five human tumors and three different cell lines to form colonies in soft agar. The inhibition is eliminated by heating to 56 degrees C and is markedly diminished by low speed centrifugation at 7000 g. This commercially available liver preparation may provide a useful tool to extend the feasibility of clonogenic assays to standard drugs and new investigational drugs whose antitumor activity is dependent upon microsomal activation.
Similar articles
-
Identification of novel enzyme-prodrug combinations for use in cytochrome P450-based gene therapy for cancer.Arch Biochem Biophys. 2003 Jan 1;409(1):197-206. doi: 10.1016/s0003-9861(02)00453-8. Arch Biochem Biophys. 2003. PMID: 12464259
-
A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.Cancer Res. 1988 Oct 1;48(19):5447-54. Cancer Res. 1988. PMID: 3046738
-
Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines.Cancer Res. 1984 Feb;44(2):549-56. Cancer Res. 1984. PMID: 6692360
-
In vitro activation of dacarbazine (DTIC) for a human tumor cloning system.Int J Cell Cloning. 1983 Apr;1(1):24-32. doi: 10.1002/stem.5530010105. Int J Cell Cloning. 1983. PMID: 6674387
-
Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes.Cancer Treat Rep. 1987 Mar;71(3):267-72. Cancer Treat Rep. 1987. PMID: 3815394
Cited by
-
Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.Cancer Chemother Pharmacol. 1985;14(2):83-95. doi: 10.1007/BF00434343. Cancer Chemother Pharmacol. 1985. PMID: 3882257 Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical